Share Twitter LinkedIn Facebook Email David Braun, M.D., Phd an Oncologist at Dana-Farber Cancer Institute in Boston MA. discusses Next Step In Single Cell RNA Sequencing at the Seventeenth International Kidney Cancer Symposium on Nov 2, 2018.
Tivozanib for RCC: Unpacking Efficacy, Safety, and Dose Optimization – Bradley McGregor, MD – Dana Farber Genitourinary 3 Mins Read
Renal Cell Carcinoma TiNivo-2 Study: Patient-Reported Outcomes in Treatment Post-ICI Kidney 3 Mins Read
VIDEO: FDA Approves Atezolizumab / Tecentriq Hybreza For Subcutaneous PD-(L)1 Cancer Immunotherapy in NSCLC Kidney 4 Mins Read